BSEInsider Trading / SAST28 Sept 2026 · 28 Sept 2026, 03:32 pm

The Intimation of closure of window for trading in securities of the Company by Designated Persons and their Immediate relatives for the quarter and half year ending on September 30, 2026, effective from October 1, 2026 is enclosed herewith. Kindly take the same on record.

Supriya Lifescience Ltd · 543434

✦ AI Summary

Supriya Lifescience Ltd has announced the closure of its trading window for insiders and designated persons from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Supriya Lifescience Ltd - 543434 - Closure of Trading Window

Attachments (1)

📄

540138c0-c7df-476e-ab60-591bb971fb87.pdf

pdf

Download →
View document text
September 28, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex Mumbai- 400 001. Bandra (E), Mumbai - 400 051. Scrip Code: 543434 NSE Symbol: SUPRIYA Dear Sir/Madam, Sub: Intimation of Trading Window Closure In accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company’s Code of Conduct to Regulate, Monitor and Report Trading in Securities by Insiders (hereinafter referred to as the "Prohibition of Insider Trading Code"), the Trading window for dealing in Securities of the Company for all Insiders and Designated Persons (including their immediate relatives), as defined in the Code, shall remain closed from Thursday, October 01, 2026 until 48 hours after the declaration of the Unaudited Financial Results by the Company for the quarter and half year ending on September 30, 2026. The date of the Board Meeting for consideration and declaration of the Unaudited Financial Results for the quarter and half year ending on September 30, 2026, shall be intimated in due course. Kindly take this information on records. Thanking you, For Supriya Lifescience Limited Prachi Sathe Company Secretary & Compliance Officer Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE